TrademarkDir
ENHANCED DRUG DELIVERY
LIVE

Serial Number

97783585

Owner

Vinci Pharmaceuticals, Inc.

Attorney

Karen K. Won

Filing Date

Feb 7, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ENHANCED DRUG DELIVERY Trademark

Serial Number: 97783585

ENHANCED DRUG DELIVERY is a trademark filed by Vinci Pharmaceuticals, Inc. on February 7, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Vinci Pharmaceuticals, Inc. (5 trademarks)

Avon by the Sea, NJ 07717

Entity Type: 03

Trademark Details

Filing Date

February 7, 2023

Registration Date

Not Registered

Published for Opposition

September 3, 2024

Goods & Services

research and development services in the field of retinal diseases; conducting clinical trials for others in the field of retinal diseases

pharmaceutical preparations for the treatment of retinal diseases

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 2, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 2, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 2, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 2, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 23, 2026 EXRA
SOU EXTENSION 4 GRANTED
Sep 22, 2026 EX4G
SOU EXTENSION 4 FILED
Sep 22, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 22, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2026 EXRA
SOU EXTENSION 3 GRANTED
Feb 27, 2026 EX3G
SOU EXTENSION 3 FILED
Feb 27, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 27, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2025 EXRA
SOU EXTENSION 2 GRANTED
Aug 27, 2025 EX2G
SOU EXTENSION 2 FILED
Aug 27, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 27, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 2, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 1, 2025 EX1G
SOU EXTENSION 1 FILED
Feb 28, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 28, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 29, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 29, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 15, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 15, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 15, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 13, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 20, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 20, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 17, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 6, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2023 NWOS
NEW APPLICATION ENTERED
Feb 10, 2023 NWAP

Related Trademarks

More from this Owner

EPIPLANT

EPIPLANT

EPIPLANT

EPIPLANT

VINCI PHARMACEUTICALS

VINCI PHARMACEUTICALS

VINCI PHARMACEUTICALS

VINCI PHARMACEUTICALS

EPIPLANT

EPIPLANT

EPIPLANT

EPIPLANT